SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-21-000204
Filing Date
2021-10-05
Accepted
2021-10-05 08:16:45
Documents
14
Period of Report
2021-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea148291-8k_180life.htm   iXBRL 8-K 40383
2 DEBT CONVERSION AGREEMENT DATED SEPTEMBER 30, 2021, BY AND BETWEEN 180 LIFE SCIE ea148291ex10-1_180life.htm EX-10.1 80612
  Complete submission text file 0001013762-21-000204.txt   354361

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE atnf-20210930.xsd EX-101.SCH 3790
4 XBRL DEFINITION FILE atnf-20210930_def.xml EX-101.DEF 26659
5 XBRL LABEL FILE atnf-20210930_lab.xml EX-101.LAB 36698
6 XBRL PRESENTATION FILE atnf-20210930_pre.xml EX-101.PRE 25277
7 EXTRACTED XBRL INSTANCE DOCUMENT ea148291-8k_180life_htm.xml XML 5583
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 211305188
SIC: 2834 Pharmaceutical Preparations